Management of haemophilia B patients with inhibitors and anaphylaxis-Reference-Cited by-同舟云学术

Management of haemophilia B patients with inhibitors and anaphylaxis

Published:1998-07 Issue:4 Volume:4 Page:574-576
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:

Author:

Lee C. A.,Kessler C. M.,Varon D.,Martinowitz U.,Heim M.,WARRIER I.

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2516.1998.440574.x/fullpdf

Reference8 articles.

1. Factor IX inhibitors and anaphylaxis in haemophilia B;Warrier;J Pediatr Hematol Oncol,1997

2. FIX inhibitor and anaphylaxis in haemophilia B correspondence;Warrier;Haemophilia,1996

3. Recombinant (r) factor VIIa (Novo-Seven) is the most appropriate treatment for children with hemophilia B complicated by inhibitor antibodies and anaphylaxis to FIX containing products;Warrier;Blood,1996

4. Bergman F Vester U Rose M Hoyer PF Bohn U Barthels M Behandlungsaltervativen bei Hemmorkörperhämophilie B: Erfahrungen mit dem Einsatz von rekombinatem Faktor VIIa (rFVIIa) Scharrer I Schramm W Springer Verlag 1994 126 9

5. The use of rFVIIa to treat a factor IX inhibitor following anaphylaxis with factor IX concentrate;Collins;Blood Coagulation and Fibrinolysis,1995

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platelet-targeted hyperfunctional FIX gene therapy for hemophilia B mice even with preexisting anti-FIX immunity;Blood Advances;2021-03-01

2. Hemophilia B;Transfusion Medicine and Hemostasis;2019

3. Inhibitors in Hemophilia B;Seminars in Thrombosis and Hemostasis;2018-06-20

4. Optimizing bleed prevention throughout the lifespan: Womb to Tomb;Haemophilia;2018-05

5. Inhibitors in Hemophilias;Hematology;2018